Therefore, to assess whether platelet‐dependent neutrophil infiltration could be blocked, in a manner with less potential systemic effects and therefore more relevant therapeutically and without reducing platelet numbers, we administered anti‐GPIbα antibody in the context of LPS‐induced brain inflammation. This evidence concerns the gene GP1BA and brain inflammatory disease.